Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients

  • Read more about CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients

Cough Sound Recordings to Understand COVID-19-like Symptom Progression to Understand COVID-19-like Symptom Progression

  • Read more about Cough Sound Recordings to Understand COVID-19-like Symptom Progression to Understand COVID-19-like Symptom Progression

Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

  • Read more about Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

Impact of COVID-19 Vaccines on Cerebrovascular Health

  • Read more about Impact of COVID-19 Vaccines on Cerebrovascular Health

A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx

  • Read more about A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx

COVID-19 Antibody Responses in Cystic Fibrosis

  • Read more about COVID-19 Antibody Responses in Cystic Fibrosis

Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster

  • Read more about Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster

RESPOND: Improving the Preparedness of Health Systems to Reduce Mental Health and Psychosocial Concerns Resulting From the COVID-19 Pandemic

  • Read more about RESPOND: Improving the Preparedness of Health Systems to Reduce Mental Health and Psychosocial Concerns Resulting From the COVID-19 Pandemic

Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized With Covid-19

  • Read more about Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized With Covid-19

PAI-1 Levels and Predicting Covid-19 Patients' Prognosis

  • Read more about PAI-1 Levels and Predicting Covid-19 Patients' Prognosis

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 203
  • Page 204
  • Page 205
  • Page 206
  • Current page 207
  • Page 208
  • Page 209
  • Page 210
  • Page 211
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA